Abstract
Tyrosinemia type III (HT III) is the rarest form of tyrosinemia, and the full clinical spectrum of this disorder is still unknown. The neurological involvement varies, including intellectual impairment and attention deficit disorder with hyperactivity (ADHD). We report the case of two siblings diagnosed with HT III at different ages. The index case was diagnosed by newborn screening for endocrine and metabolic disorders, starting a low-protein diet immediately, with a consistent decrease in tyrosine levels. By the age of three, the child displayed a hyperactive behavior, starting treatment for ADHD two years later. At seven years of age, he shows a slight improvement in terms of behavior and attention span and has a cognitive performance slightly lower than his peers, despite maintaining acceptable tyrosine levels. His sister, who had a history of ADHD since age five, was diagnosed with HT III after family screening at the age of eight. Despite initiating a dietetic treatment, her behavior did not improve, and she has a mild intellectual impairment. This is the first case report describing siblings with HT III who underwent nutritional treatment with a low-protein diet in different phases of life, with a better neurological and...Continue Reading
References
Jan 1, 1992·Journal of Inherited Metabolic Disease·P D'EufemiaR Finocchiaro
Jan 1, 1983·Pediatric Research·O GiardiniP D'Eufemia
Feb 1, 1983·Pediatric Research·F EndoI Matsumoto
Jan 1, 1995·Journal of Inherited Metabolic Disease·P D D'EufemiaO Giardini
Oct 29, 1997·Acta Paediatrica·R CeroneC Romano
Aug 15, 2000·Human Genetics·U RüetschiE Holme
Nov 14, 2000·Molecular Genetics and Metabolism·K TomoedaF Endo
May 24, 2001·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·P A RussoR M Tanguay
Mar 28, 2002·Journal of Inherited Metabolic Disease·C J EllawayJ V Leonard
Jul 29, 2008·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Patrizia D'EufemiaAlessandra Zicari
Jul 27, 2011·Metabolic Brain Disease·Rodrigo Binkowski de AndradeClovis Milton Duval Wannmacher
Oct 6, 2012·Molecular Genetics and Metabolism·Evelyne HeylenMarie-Cécile Nassogne
Oct 19, 2013·Neurochemical Research·Livia G R P MacêdoEmilio L Streck
Dec 4, 2013·Neurochemical Research·Samira D T De PráEmilio L Streck
Oct 4, 2016·European Child & Adolescent Psychiatry·A SimonsD van West
Dec 8, 2016·Metabolic Brain Disease·Brena P TeodorakEmilio L Streck
Oct 22, 2015·Molecular Genetics and Metabolism Reports·Edyta SzymanskaAnna Tylki-Szymanska